Supernus Pharmaceuticals (S49.F) Q1 2024 Earnings

Feb 27Confirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.27
-0.01
0.25
0.52

Details

Expected EPS
0.5165328
Actual EPS
0.0184476
Surprise EPS
-0.5
Surprise Percent
-96.43%

Description

⁨Supernus Pharmaceuticals⁩ (⁦S49.F⁩) has reported earnings of ⁦0.0184476⁩ per share for ⁦Q1 2024⁩.

0 Comments

Share your thoughts